M62.52 Muscle wasting and atrophy, not elsewhere classified, upper arm

Name of the Condition

• Muscle wasting and atrophy, not elsewhere classified, upper arm (ICD-10-CM: M62.52)

Summary

Muscle wasting and atrophy of the upper arm, not elsewhere classified, refers to the loss of muscle mass and strength in the upper arm region that is not attributed to a specific, more defined condition. This can result from disuse, underlying systemic issues, or other non-specific factors, leading to reduced upper arm function and potential functional impairment.

Causes

Causes may include prolonged immobility, malnutrition, chronic illness, or metabolic disturbances affecting the upper arm muscles. In some cases, the underlying cause remains unidentified, and the condition may arise without a clear precipitating factor.

Risk Factors

• Prolonged bed rest or inactivity affecting the upper arm
• Advanced age
• Chronic diseases (e.g., cancer, kidney disease)
• Malnutrition or poor dietary intake
• Certain medications (e.g., corticosteroids)
• Neurological conditions affecting muscle control

Symptoms

• Gradual loss of muscle mass or visible shrinking of upper arm muscles
• Reduced strength or difficulty performing upper arm-related tasks (e.g., lifting, reaching)
• Fatigue or weakness during upper arm activity
• Changes in muscle tone or appearance in the upper arm area

Diagnosis

Diagnosis typically involves a physical examination to assess upper arm muscle size and strength, patient history to identify potential contributing factors, and may include blood tests to evaluate nutritional or metabolic status. Imaging or electromyography may be used in select cases to rule out other conditions.

Treatment Options

Treatment focuses on addressing underlying causes, such as improving nutrition, increasing physical activity, or managing chronic conditions. Physical therapy may help restore strength and function. In some cases, medications or other interventions may be considered based on the underlying etiology.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and the effectiveness of treatment. Regular follow-up may be necessary to monitor muscle strength, functional status, and response to interventions. Early intervention can improve outcomes, particularly if disuse or reversible factors are involved.

Complications

Potential complications include persistent weakness, reduced mobility, increased risk of falls, and decreased quality of life. Severe or prolonged atrophy may lead to irreversible muscle changes.

Lifestyle & Prevention

• Engage in regular, targeted exercise to maintain muscle mass.
• Ensure adequate protein and nutrient intake.
• Avoid prolonged immobility; use assistive devices if needed.
• Manage chronic conditions that may contribute to muscle loss.

When to Seek Professional Help

Seek medical attention if you notice unexplained muscle loss, weakness, or difficulty performing daily activities. Prompt evaluation is important to identify and address underlying causes.

Tips for Medical Coders

Document the specific location (upper arm) and any contributing factors, such as immobility or chronic illness, to support code assignment. Ensure the condition is not better classified under a more specific code for muscle wasting or atrophy. Verify that no other specified codes apply before using M62.52.